Frequency of five thrombophilic polymorphisms in the Egyptian population

Turkish Journal of Hematology

Volumn 23, Issue 2, 2006, Pages 100-103

  Ulu, Arzu ^a   Elsobky, Ezzat ^b   Elsayed, Mohamed ^b   Yildiz, Züleyha ^a   Tekin, Mustafa ^a   Akar, Nejat ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Polymorphism; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL PROTEIN C RECEPTOR; PROTHROMBIN;

ADULT; ARTICLE; EGYPT; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; HAPLOTYPE; HOMOZYGOSITY; HUMAN; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THROMBOPHILIA; THROMBOSIS;

EID: 33846140469     PISSN: 13007777     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Reich LM, Bower M, Key NS. Role of the geneticist in testing and counseling for inherited thrombophilia. Genet Med 2003;5:133-43.
2. Zoller B, Garcia de Frutos P, Hillarp A, Dahlback B. Thrombophilia as a multigenic disease. Haematologica 1999;84:59-70.
3. Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP. Resistance to activated protein C and factor V Leiden as risk factor for venous thrombosis. Thromb Haemost 1995;74:449-53.
4. Lunghi B, Iacoviello L, Gemmati D, Dilasio MG, Castoldi E, Pinotti M, Castaman G, Redaelli R, Mariani G, Marchetti G, Bernardi F. Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma. Thromb Haemost 1996;75:45-8.
5. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
6. Esmon CT. The endothelial protein C receptor. Thromb Haemost 2000;83:639-43.
7. Okumus G, Arseven O. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene: really a risk factor for venous thromboembolism? Thromb Haemost 2003;90:766-7.
8. Zecchina G, Bosio S, Brusa E, Rege-Cambrin G, Camaschella C. EPCR 23 bp insertion in a patient with arterial disease: a dominant loss of function mutant in conditions of increased APC request? Br J Haematol 2002; 119:881-2.
9. Lunghi B, Castoldi E, Mingozzi F, Bernardi F. A new factor V gene polymorphism (His 1254 Arg) present in subjects of African origin mimics the R2 polymorphism (His 1299 Arg). Blood 1998;91:364-5.
10. Akar N, Aras O, Omurlu K, Cin S. Deletion polymorphism at the angiotensin-converting enzyme gene in Turkish patients with coronary artery disease and controls. Scand J Clin Lab Invest 1998;58:491-5.
11. Akar N, Gokdemir R, Ozel D, Akar E. Endothelial cell protein C receptor (EPCR) gene exon III 23 bp insertion mutation in the Turkish pediatric thrombotic patients. Thromb Haemost 2002;88:1068-9.
12. Akar N, Akar E, Yilmaz E. Factor V (His 1299 Arg) in Turkish patients with venous thromboembolism. Am J Hematol 2000;63:102-3.
13. Pawar AR, Shetty S, Ghosh K, Mohanty D. How old is factor V Leiden mutation? Thromb Haemost 2001;86:1591-2.
14. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-4.
15. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 1997;277:1305-7.